WTR Healthcare Happenings
tekijä: Joe Brunetto
Uusin jakso
Beyond GLP-1s: The Expanding Frontier of Peptide Therapeutics
Beyond GLP-1s: The Expanding Frontier of Peptide Therapeutics
Tietoa podcastista
WTR Healthcare Happenings is a weekly conversation with healthcare executives, medical experts, and investors on recent clinical data or industry-driving events in healthcare.
Jaksot
Uusimmat 20 jaksoa 70 jaksosta
- Beyond GLP-1s: The Expanding Frontier of Peptide Therapeutics · 11 minIn this episode of the WTR Healthcare Happenings podcast, WTR Healthcare Analyst Robert Sassoon joins host Tim Gerdeman to discuss his newly published industry report, Primer…
- The 2026 Midterms: Why This Is a Coverage Election for Healthcare Investors · 18 minIn this episode of WTR Healthcare Happenings, Tommy Barletta, Co-Founder and Managing Partner of ALDIS Institutional Services, joins host Tim Gerdeman, Co-Founder of Water Tower…
- Solvonis Therapeutics (SVNS): European Phase 3 Expansion and a Growing CNS Opportunity · 32 minIn this episode of WTR Healthcare Happenings, Anthony Tennyson, CEO of Solvonis Therapeutics (LSE: SVNS), joins WTR healthcare analyst Robert Sassoon and host Tim Gerdeman…
- PharmAla Biotech (MDMA): Good MDMA Today, Better MDMA Tomorrow · 14 minIn this episode of WTR Healthcare Happenings, Robert Sassoon, Managing Director and Healthcare Analyst at Water Tower Research, joins host Tim Gerdeman, Co-Founder of Water Tower…
- Circular Genomics: Predicting Who Will Develop Alzheimer’s and When · 12 minIn this episode of WTR Healthcare Happenings, Robert Sassoon, Managing Director of Healthcare Equity Research at Water Tower Research, joins host Tim Gerdeman to discuss his…
- eXoZymes (EXOZ): Can Cell-Free Biomanufacturing Deliver at Commercial Scale? · 10 minIn this episode of WTR Healthcare Happenings, Robert Sassoon, Managing Director and healthcare analyst at Water Tower Research, joins host Tim Gerdeman to discuss his newly…
- Vivos Therapeutics, Inc. (VVOS): Deleveraging, Driving Referrals, and Building Toward Positive Cash Flow · 31 minIn this episode of WTR Healthcare Happenings, Kirk Huntsman, CEO of Vivos Therapeutics (NASDAQ: VVOS), joins WTR healthcare analyst Robert Sassoon and host Tim Gerdeman to break…
- Natural MedTech: Why the Psychedelic Opportunity Starts With Manufacturing · 45 minIn this episode of WTR Healthcare Happenings, Natural MedTech CEO and Co-Founder Luke McFarlane joins WTR healthcare analyst Robert Sassoon and Shawn Severson to discuss the…
- Cannara Biotech (LOVFF): Gaining Share in the Canadian Cannabis Market · 23 minIn this episode, Cannara Biotech COO and Interim CFO Nick Sosiak joins WTR's Linda Bolton Weiser and Tim Gerdeman to discuss the company's expansion following the announcement of…
- Oncolytics Biotech (ONCY): A Differentiated Approach to Treating Gastrointestinal Cancers · 25 minIn this episode of WTR Healthcare Happenings, Oncolytics Biotech CEO Jared Kelly joins WTR's Tim Gerdeman and healthcare analyst Robert Sassoon to discuss the company's progress…
- The Psychedelic Inflection Point: Big Pharma, FDA, and the Next Wave of Brain Medicines · 22 minIn this episode of WTR Healthcare Happenings, Doug Drysdale, biopharma veteran and founder of Katagen, former CEO of Cybin (now Helus Pharma), joins WTR's Tim Gerdeman and…
- Pulsenmore (PLSM): Safe and Sound: Pulsenmore Brings Prenatal Ultrasound Home · 24 minDr. Elazar Sonnenschein, Founder and CEO of Pulsenmore Ltd. (Nasdaq and Tel Aviv: PLSM), joins host Tim Gerdeman and WTR equity research analyst James Kisner on this episode of…
- Biotech M&A Is Back: What's Driving the 2026 Deal Surge · 11 minIn this episode of WTR Healthcare Happenings, host Tim Gerdeman is joined by healthcare equity research analyst Robert Sassoon to discuss the rebound in biotech and pharma M&A…
- Jupiter Neurosciences (JUNS): Jotrol’s Bioavailability Breakthrough and the Key Parkinson’s Phase 2A Readout · 23 minIn this episode, Christer Rosen, Founder and CEO of Jupiter Neurosciences (Nasdaq: JUNS), and President & COO Alison Silva join Water Tower Research’s Tim Gerdeman and Healthcare…
- NurExone Biologic (NRX): The Inhibitor of the Inhibitor: How Nurexone's ExoPTEN Is Designed to Restart Nerve Regeneration · 12 minIn this episode of Healthcare Happenings, Robert Sassoon, WTR healthcare equity analyst, joins host Tim Gerdeman to discuss his initiation of coverage on NurExone Biologic (TSXV…
- PharmAla Biotech (MDMA): Two Transactions, One Strategy: Unlocking Pipeline Value Through Structured Partnerships · 18 minIn this episode of Healthcare Happenings, Nick Kadysh, Founding CEO and President of PharmAla Biotech (CSE: MDMA / OTCQB: MDXXF), joins host Tim Gerdeman and WTR healthcare…
- Solvonis Therapeutics (SVNS): CSO Professor David Nutt on Solvonis' Approach to Resetting the Addicted Brain · 22 minIn this special episode of the WTR Healthcare Happenings podcast, the second in a two-part series, Professor David Nutt, Chief Science Officer of Solvonis Therapeutics (LSE…
- Solvonis Therapeutics (SVNS): Rewriting the Standard of Care for Severe Alcohol Use Disorder · 34 minIn this special episode of Healthcare Happenings, the first in a two‑part series, Anthony Tennyson, CEO of Solvonis Therapeutics (LSE: SVNS), joins host Tim Gerdeman and WTR…
- PetVivo Holdings (PETV): The Trifecta: Regenerative Science, AI-Enabled Vet Care, and Human Translation · 27 minIn this episode of Healthcare Happenings, John Lai, CEO of PetVivo Holdings (PETV), joins host Tim Gerdeman and WTR analyst Robert Sassoon to discuss the company's regenerative…
- SBC Medical (SBC): Scaling Aesthetics, Longevity, and Global Growth · 21 minIn this episode of the WTR Healthcare Happenings podcast, Stephen Rodgers, Head of Global Planning and Strategy at SBC Medical Group Holdings (NASDAQ: SBC), joins WTR’s Tim…








